Claim CME
The deadline for claiming CME for this event was June 15, 2026.
Please contact [email protected] if you require assistance.
Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Interventional Cardiology Program Credit Designation
SCAI designates this live activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Congenital Heart Disease Program Credit Designation
SCAI designates this live activity for a maximum of 18.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 17.75 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
ABP MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.5 medical knowledge MOC points in the American Board of Pediatric’s (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Nurses
Nurses, including Registered Nurses (RNs) and Nurse Practitioners (NPs), can receive and use AMA PRA Category 1 Credit™️ to fulfill Nursing CPD and recertification requirements with most certifying bodies and state licensure boards. Please check with your state for specific requirements.
Radiologic Technicians
This education activity is pending approval by the Association for Vascular and Interventional Radiographers (AVIR) for up to 18.5 A+ credit hours.
Successful Completion
Check into the conference onsite and pick up your badge. This creates an attendance record. Participate in the program. Then, complete the post-activity evaluation to claim credit.
SCAI-Sponsored Satellite Symposia Programming
In addition to the Scientific Sessions program described above, SCAI offers CME satellite symposia opportunities. These symposia represent a possible additional 8 AMA PRA Category 1 CreditsTM. CE information for the satellite symposia can be found in the Conference Program.
Acknowledgement of Commercial Support
This activity is supported by unrestricted educational grants from Abbott, Boston Scientific, Chiesi, Cook Medical, Cordis, Edwards Lifesciences, InspireMD, Medtronic, Shockwave Medical, Teleflex, Terumo, W.L. Gore & Associates.
Disclosures
Individuals in control of content disclosed the following relevant relationships with ineligible companies during the content development process for this activity.
Program Committee/Planners
Program Chairs
- Sahil Parikh: Abbott, Boston Scientific Corp, Medtronic, Philips, advisory board. Abiomed (J&J), Inari, Penumbra, Terumo, consulting.
- Andrew Klein: No financial relationships with ineligible companies.
- Fred Welt: Xenter Inc, consulting, stock options.
Congenital Heart Disease Program
- Howaida El-Said: Merit Medical and Starlight Vascular, consulting.
- Athar M. Qureshi: B Braun, Medtronic, W.L. Gore and Associates, Inc, consulting
- Holly Bauser: No financial relationships with ineligible companies.
Coronary Track
- Rajan Patel, Track Director: Abiomed (J&J), consulting, speaker. Boston Scientific Corp, speaker.
- Andrea Lavoie: Pfizer, Boehringer Ingelheim, Novo Nordisk, HLS Therapeutics, and Servier, advisory board, speaker. ICEBM and Novartis, speakers.
- Mina Madan: Medtronic, consulting. Novo Nordisk, consulting, PI.
- Samer Mansour: Abiomed (J&J), advisory board. Abbott and Medtronic, speaker.
- Margaret McEntegart: Boston Scientific Corp, consulting. Shockwave Medical, PI.
- Evan Shlofmitz: Abbott, ACIST Medical, Boston Scientific Corp, Philips, Nipro Medical, Radiaction, Shockwave Medical, consulting.
- Alexander Truesdell: Abiomed (J&J), consulting. Getinge, Shockwave, speaker. Zoll, consulting, speaker.
Interventional Leadership Track
- Pinak Bipin "Binny" Shah, Track Director; Amit Vora, Tara Jones, Tayo Addo: No relevant financial relationships with ineligible companies.
Peripheral Track
- Jun Li, Track Director: Abbott, Boston Scientific Corp, Inari Medical, Medtronic, consulting.
- Peter Monteleone: Medtronic, advisory board, consulting, speaker. Boston Scientific Corp, advisory board, consulting, speaker.
- Sonal Pruthi: No financial relationships with ineligible companies.
- Peter Soukas: Abbott, consulting. AVS, Bard, Contego Medical, MicroMedical Solutions, Penumbra, Reva Medical, Reflow Medical, and Sound Bite, PI. Boston Scientific Corp, advisory board, consulting. Endologix, advisory board, consulting, PI. Shockwave Medical, advisory board, consulting, PI. W.L. Gore and Associates, Inc, consulting, PI.
Structural Track
- Molly Szerlip, Track Director: Abbott, advisory board, PI. Boston Scientific Corp, advisory board. Edwards Lifesciences, consulting, PI, speaker. Medtronic, PI.
- Anita Asgar: Abbott and Medtronic, advisory board. W.L. Gore and Associates, Inc, advisory board, consulting. Edwards Lifesciences and Philips, consulting.
- Janine Eckstein: No financial relationships with ineligible companies.
- Sam Radhakrishnan: Boston Scientific and Edwards Lifesciences, PI. Medtronic, advisory board, consulting, PI.
- Triston Smith: No financial relationships with ineligible companies.
- Michael Young: Boston Scientific Corp, advisory board, PI.
- David Wood: No financial relationships with ineligible companies.
Staff: Robert Bartel and Rachel Pham have no financial relationships with ineligible companies.
Faculty disclosures can be found in the Conference App under the Faculty Listing.
Independent Content
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
Planning Process
The SCAI 2026 Scientific Sessions were developed by the SCAI planners prior to and independent of commercial support. Members of the Program Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.
All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.
Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.